Clinical Trial in Prostate Cancer Patients Planned for Generic Form of Trelstar

Clinical Trial in Prostate Cancer Patients Planned for Generic Form of Trelstar
Xbrane Biopharma announced that it will conduct a clinical trial in prostate cancer patients to assess Spherotide, its one-month generic formulation of Trelstar (triptorelin), to support its plans to submit a Marketing Authorization Application (MAA) to the European Union for approval. The single clinical study was advised by the German Federal Institute for Drugs and Medical Devices (BfArM), which reviewed the

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , , .

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

One comment

  1. Jonathan Roid says:

    It is always good to see news like this, we need more options when it comes about a topic like this. I am against surgery, my urologist offered it to me as the only option but I just didnt want to so I talked to some of my friends and one of them introduced me to his doctor and he told me surgery is not the only option, He prescribed me a supplement named alpharise that has good components for the prostate such as zinc, vitamin B9 and others, also told me I needed to quit many bad habits such as smoking ( The other doc didnt tell me about it), I can tell based on my own experience that surgery is not the only option and if you want to try with a natural treatment try with a better alimentation, better habits and alpharise.

Leave a Comment

Your email address will not be published. Required fields are marked *